Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae.
about
Panel 5: Microbiology and immunology panelRegulation of virulence gene expression resulting from Streptococcus pneumoniae and nontypeable Haemophilus influenzae interactions in chronic diseaseRespiratory syncytial virus promotes Moraxella catarrhalis-induced ascending experimental otitis mediaImproving patient care via development of a protein-based diagnostic test for microbe-specific detection of chronic rhinosinusitisPanel 6: Vaccines.Transcriptional portrait of Actinobacillus pleuropneumoniae during acute disease--potential strategies for survival and persistence in the host.Panel 3: Recent advances in anatomy, pathology, and cell biology in relation to otitis media pathogenesis.Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.Antibodies against the majority subunit of type IV Pili disperse nontypeable Haemophilus influenzae biofilms in a LuxS-dependent manner and confer therapeutic resolution of experimental otitis media.Antisera Against Certain Conserved Surface-Exposed Peptides of Nontypeable Haemophilus influenzae Are Protective.Expression, purification, crystallization and preliminary crystallographic analysis of PilA from the nontypeable Haemophilus influenzae type IV pilus.Therapeutic Transcutaneous Immunization with a Band-Aid Vaccine Resolves Experimental Otitis Media.What's on the Outside Matters: The Role of the Extracellular Polymeric Substance of Gram-negative Biofilms in Evading Host Immunity and as a Target for Therapeutic Intervention.Monoclonal antibodies against DNA-binding tips of DNABII proteins disrupt biofilms in vitro and induce bacterial clearance in vivo.Adjuvants for human vaccines.Transcutaneous Immunization with a Band-Aid Prevents Experimental Otitis Media in a Polymicrobial Model.Intercellular adhesion molecule 1 serves as a primary cognate receptor for the Type IV pilus of nontypeable Haemophilus influenzae.Type IV Pilus Expression Is Upregulated in Nontypeable Haemophilus influenzae Biofilms Formed at the Temperature of the Human Nasopharynx.Biological roles of nontypeable Haemophilus influenzae type IV pilus proteins encoded by the pil and com operons.Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization.Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins.The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
P2860
Q26829692-E229D8FE-281D-486B-9511-DFF77C59AD63Q28478266-69522D76-A3AC-4F7F-8D07-24553C6DD799Q30465967-C6061502-2731-46D2-82C1-1730208377A1Q33609255-2E77EA11-4118-4F1E-A135-EE001B24F530Q33644678-9F721307-7287-402E-A594-0EFDC8D6BF69Q34243882-045F5844-687F-4975-B14C-FB90D1F1794FQ34638844-6AB5621E-E44E-4089-804A-715A7F14CEBDQ35548019-FC6F6326-83D1-4823-9FEC-EB1CA56CB510Q35579952-708EA19D-CF52-4DAB-890C-200F220583B4Q35782062-0047E327-B458-4F81-8181-90078EBA80F9Q35847151-3226C224-5983-4E29-966C-F2B01DF60FCBQ35901982-E095AF96-25F8-43F6-9CD8-1BAD5E01304AQ37066508-80530046-7069-43F6-92AE-4A6F33789E19Q37221382-2A4C78CB-01B7-4D8C-9E39-CAA31B24F8AFQ38004229-5AAD5BD1-B4AD-4AC8-B712-896D60E7BC24Q38851718-3CDBD2A5-4D09-40AF-A773-BB11D7C93E84Q40013210-22BD8C8D-DCB3-46E5-AD34-E86D6D282DC2Q40728738-C32103E3-A001-4A62-B41E-7C1889C664D1Q42007166-FAF1A8EB-35A7-405A-BDC8-C8554F558FDCQ43243181-73EDD1B0-8F38-480C-9C2D-DBA82CDD0247Q46927233-3080A3A4-3A08-4026-92C4-8ED426D7A154Q57945015-BFB6E83D-BCD6-489D-8C9D-6D27B20BC984
P2860
Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Transcutaneous immunization as ...... peable Haemophilus influenzae.
@en
Transcutaneous immunization as ...... peable Haemophilus influenzae.
@nl
type
label
Transcutaneous immunization as ...... peable Haemophilus influenzae.
@en
Transcutaneous immunization as ...... peable Haemophilus influenzae.
@nl
prefLabel
Transcutaneous immunization as ...... peable Haemophilus influenzae.
@en
Transcutaneous immunization as ...... peable Haemophilus influenzae.
@nl
P2093
P2860
P356
P1433
P1476
Transcutaneous immunization as ...... peable Haemophilus influenzae.
@en
P2093
J D Clements
L A Novotny
L O Bakaletz
P2860
P2888
P304
P356
10.1038/MI.2011.6
P577
2011-02-16T00:00:00Z